Literature DB >> 25210123

Dissecting the contribution of IgG subclasses in restricting airway infection with Legionella pneumophila.

Stefan S Weber1, Jasmin Ducry1, Annette Oxenius2.   

Abstract

Abs are able to mediate local protection from pulmonary infection with Legionella pneumophila, the causative agent of a severe form of pneumonia known as Legionnaires' disease. L. pneumophila is able to infect alveolar macrophages in the lung and replicates intracellularly in a vacuolar compartment with endoplasmic reticulum-like characteristics. However, Abs opsonize the bacteria and confer an FcR-mediated signal to phagocytic host cells that vetoes the bacterial evasion strategies, thereby efficiently targeting the bacteria to intracellular lysosomal degradation. In this study we analyzed the prevalence of pathogen-specific IgG subclasses present in immunized mice and found that the presence of IgG2c and IgG3 correlated with reduced bacterial titers after intranasal infection. We then isolated different IgG subclasses and compared their differential prophylactic potential in restricting airway L. pneumophila replication. We found that all IgG subclasses were effective in restricting pulmonary airway infection in mice when administered at high and equivalent doses. However, at limiting Ab concentrations we found a superior role of IgG2c in restricting L. pneumophila replication in a prophylactic setting. Furthermore, we assessed the therapeutic efficacy of administering an mAb during an established infection and found that bacterial titers could be reduced very efficiently with such a treatment. Thus, we propose the therapeutic use of Abs for the treatment of intracellular bacterial infections in situations where antibiotics might be ineffective.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25210123     DOI: 10.4049/jimmunol.1401031

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19.

Authors:  Athanasios Blanas; Haiko Karsjens; Aafke de Ligt; Elisabeth J M Huijbers; Karlijn van Loon; Stepan S Denisov; Canan Durukan; Diederik J M Engbersen; Jan Groen; Sven Hennig; Tilman M Hackeng; Judy R van Beijnum; Arjan W Griffioen
Journal:  iScience       Date:  2022-07-05

2.  Cancer Vaccination against Extracellular Vimentin Efficiently Adjuvanted with Montanide ISA 720/CpG.

Authors:  Karlijn van Loon; Elisabeth J M Huijbers; Jan David de Haan; Arjan W Griffioen
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

Review 3.  Viewing Legionella pneumophila Pathogenesis through an Immunological Lens.

Authors:  Xin Liu; Sunny Shin
Journal:  J Mol Biol       Date:  2019-07-25       Impact factor: 6.151

4.  TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization.

Authors:  Xinyue Chang; Pascal Krenger; Caroline C Krueger; Lisha Zha; Jiami Han; Alexander Yermanos; Salony Roongta; Mona O Mohsen; Annette Oxenius; Monique Vogel; Martin F Bachmann
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

5.  Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis.

Authors:  Victor Araujo Correa; Amanda Izeli Portilho; Elizabeth De Gaspari
Journal:  Diseases       Date:  2022-07-19

6.  Antibodies against invasive phenotype-specific antigens increase Mycobacterium avium subspecies paratuberculosis translocation across a polarized epithelial cell model and enhance killing by bovine macrophages.

Authors:  Jamie L Everman; Luiz E Bermudez
Journal:  Front Cell Infect Microbiol       Date:  2015-08-07       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.